TopStocksTrader Newsletter

About the Substack

Welcome to our publication which offers investment ideas in today's dynamic markets. Our subscription rates are very low; offering the best value for the individual investor. With weekly 100% winners; you could earn back your cost in a single trade!

Free Subscription Benefits

  • Frequent Public Posts

Paid Subcription Benefits

  • Subscriber-only posts and Full Posts Archive
  • Post comments and join the community
  • Special Alerts for Hot Stocks, Crypto & Options

Paid Subscription Plans

  • $9.99 a month
  • $69.99 a year

About TopStocksTrader

Long time professional just trying to help people make sense of the markets, trends, crypto and trends. Not a financial advisor

Is this your Substack? Submit changes.

TopStocksTrader Newsletter's recommended Substacks

SmartReversalsโ€™ Trading Compass logo
SmartReversals

SmartReversalsโ€™ Trading Compass

Daily levels for SPX - I decode with technical analysis and price levels U.S. indices, the Magnificent 7, ETFs, and other megacaps 3x per week.

100+
paid subscribers
28K+
free subscribers
Block Scholes Research logo
Andrew Melville

Block Scholes Research

Crypto Market Research, discovering market-leading insights in crypto-asset derivatives, trusted by global financial institutions.

The Setup Factory logo
The Setup Factory

The Setup Factory

Welcome to TSF. โ€ข A 4x weekly swing trading publication โ€ข A private Discord community of 400+ traders โ€ข The Setup Factory Analytics Platformโ€” a proprietary thematic relative strength and stock screening platform thesetupfactory.com

100+
paid subscribers
5K+
free subscribers
The Market Dispatch logo
The Market Dispatch

The Market Dispatch

Monthly, data-driven insights on U.S. equities and macro trends โ€” clear, concise, and actionable.

2K+
free subscribers
The M&A Hunter logo
The M&A Hunter

The M&A Hunter

Tracking biotech acquisition targets before big pharma strikes. Featuring acquisition targets with detailed analysis M&A probability signals and catalysts Valuation insight and deal timing estimates Big pharma strategy patterns "NOT Pro Advice"

100+
paid subscribers
1K+
free subscribers